Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency

Fig. 1

The testing algorithm is summarized. In both countries (Spain and Germany), the initial analysis consisted of the screening device (AlphaKit® QuickScreen) and the acquisition of blood on DBS (dried blood spot – AlphaKit). If the DBS-derived AAT serum level was ≥110 mg/dl and genotyping for the Z- and S-allele was negative, AATD was considered as excluded. All other samples underwent phenotyping to obtain a final result. DBS: dried blood spot; WBS: whole blood sample

Back to article page